GlassScriptPhysician profile
Ronald Anthony Hall
NPI 1568458545
$2,730.29
in general payments reported to CMS, 2019-2025
10 companies · $26.04 in 2025
The $26.04 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,036 · 2020: $549 · 2021: $328 · 2022: $264 · 2023: $254 · 2024: $272 · 2025: $26.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $552.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $552.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,280.46 | 2019-2023 | Mako |
| Omnilife Science, INC | $625.71 | 2019 | |
| Smith+Nephew, INC. | $261.01 | 2022-2024 | Bioinductive Implant With Arthroscopic Delivery System - Medium |
| Depuy Synthes Sales INC. | $185.33 | 2023-2024 | Dynacord, Fibergraft Aeridyan Matrix, Tfn-Advance |
| Abbott Laboratories | $122.47 | 2021 | |
| Zimmer Biomet Holdings, INC. | $89.78 | 2022-2023 | Mymobility Platform |
| Corin USA | $75.34 | 2019 | |
| Avanos Medical | $35.00 | 2019 | |
| Ermi LLC | $29.15 | 2023 | |
| Pacira Pharmaceuticals Incorporated | $26.04 | 2025 | Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Hall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.